Litcius/Paper detail

Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells

Warren Fiskus, Taghi Manshouri, Christine Birdwell, Christopher P. Mill, Lucia Masárová, Prithviraj Bose, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Joseph D. Khoury, Srđan Verstovšek, Kapil N. Bhalla

2022Blood Cancer Journal13 citationsDOIOpen Access PDF

Topics & Concepts

Myeloproliferative neoplasmNeoplasmMedicineHematologyInternal medicineMyeloproliferative DisordersLeukemiaOncologyCancer researchBone marrowPathologyMyelofibrosisAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells | Litcius